Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · John Wiley & Sons (WLY)

Wiley appoints Karen N. Madden to Board of Directors, names her to Audit Committee

Neutral Impact 2 of 5 leadership Written later

Wiley's board elected Dr. Karen N. Madden, Senior Vice President and Chief Technology Officer at MilliporeSigma, as a director effective February 28, 2025, and appointed her to the Audit Committee. The filing describes her as independent under NYSE rules and sets out her non-employee director pay, which is routine for a board addition and adds an independent director with R&D and innovation expertise.

Key points

  • Board election effective February 28, 2025; announced March 5, 2025
  • Annual cash retainer of $85,000 and annual restricted stock award of $130,000
  • Appointed to the Audit Committee; board determined she is independent under NYSE rules
  • Previously Senior Vice President and Chief Innovation Officer at PerkinElmer

The filing

CompanyJohn Wiley & Sons (WLY)
Form8-K, current report
Filed with the SECMar 5, 2025, 9:02 AM ET
Accession number0000107140-25-000012

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.